312 related articles for article (PubMed ID: 30201409)
21. Autotaxin in liver fibrosis.
Ikeda H; Yatomi Y
Clin Chim Acta; 2012 Nov; 413(23-24):1817-21. PubMed ID: 22820036
[TBL] [Abstract][Full Text] [Related]
22. Lysophosphatidic acid generation by pulmonary NKT cell ENPP-2/autotaxin exacerbates hyperoxic lung injury.
Nowak-Machen M; Lange M; Exley M; Wu S; Usheva A; Robson SC
Purinergic Signal; 2015 Dec; 11(4):455-61. PubMed ID: 26306905
[TBL] [Abstract][Full Text] [Related]
23. Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.
Alioli C; Demesmay L; Peyruchaud O; Machuca-Gayet I
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408784
[TBL] [Abstract][Full Text] [Related]
24. Autotaxin emerges as a therapeutic target for idiopathic pulmonary fibrosis: limiting fibrosis by limiting lysophosphatidic acid synthesis.
Tager AM
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):563-5. PubMed ID: 23125419
[No Abstract] [Full Text] [Related]
25. Structure-function relationships of autotaxin, a secreted lysophospholipase D.
Hausmann J; Perrakis A; Moolenaar WH
Adv Biol Regul; 2013 Jan; 53(1):112-7. PubMed ID: 23069371
[TBL] [Abstract][Full Text] [Related]
26. Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axis.
Cao P; Walker NM; Braeuer RR; Mazzoni-Putman S; Aoki Y; Misumi K; Wheeler DS; Vittal R; Lama VN
Sci Rep; 2020 Dec; 10(1):21231. PubMed ID: 33277571
[TBL] [Abstract][Full Text] [Related]
27. MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia.
Plastira I; Bernhart E; Joshi L; Koyani CN; Strohmaier H; Reicher H; Malle E; Sattler W
J Neuroinflammation; 2020 Apr; 17(1):127. PubMed ID: 32326963
[TBL] [Abstract][Full Text] [Related]
28. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
Ryu JM; Han HJ
Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
[TBL] [Abstract][Full Text] [Related]
29. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis.
Bai Z; Cai L; Umemoto E; Takeda A; Tohya K; Komai Y; Veeraveedu PT; Hata E; Sugiura Y; Kubo A; Suematsu M; Hayasaka H; Okudaira S; Aoki J; Tanaka T; Albers HM; Ovaa H; Miyasaka M
J Immunol; 2013 Mar; 190(5):2036-48. PubMed ID: 23365076
[TBL] [Abstract][Full Text] [Related]
30. Signalling by lysophosphatidate and its health implications.
Hemmings DG; Brindley DN
Essays Biochem; 2020 Sep; 64(3):547-563. PubMed ID: 32451553
[TBL] [Abstract][Full Text] [Related]
31. [Function and biological activities of the autotaxin-LPA axis].
Li ZW; Zhao YR; Zhao C; Fu R; Li ZY
Sheng Li Xue Bao; 2011 Dec; 63(6):601-10. PubMed ID: 22193457
[TBL] [Abstract][Full Text] [Related]
32. Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice.
Dong YL; Duan XY; Liu YJ; Fan H; Xu M; Chen QY; Nan Z; Wu H; Deng SJ
Inflammation; 2019 Oct; 42(5):1530-1541. PubMed ID: 31102124
[TBL] [Abstract][Full Text] [Related]
33. Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model.
Nikolaou A; Ninou I; Kokotou MG; Kaffe E; Afantitis A; Aidinis V; Kokotos G
J Med Chem; 2018 Apr; 61(8):3697-3711. PubMed ID: 29620892
[TBL] [Abstract][Full Text] [Related]
34. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
Orosa B; García S; Conde C
Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
[TBL] [Abstract][Full Text] [Related]
35. Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry.
Cuozzo JW; Clark MA; Keefe AD; Kohlmann A; Mulvihill M; Ni H; Renzetti LM; Resnicow DI; Ruebsam F; Sigel EA; Thomson HA; Wang C; Xie Z; Zhang Y
J Med Chem; 2020 Jul; 63(14):7840-7856. PubMed ID: 32584034
[TBL] [Abstract][Full Text] [Related]
36. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target.
Ntatsoulis K; Karampitsakos T; Tsitoura E; Stylianaki EA; Matralis AN; Tzouvelekis A; Antoniou K; Aidinis V
Front Immunol; 2021; 12():687397. PubMed ID: 34671341
[TBL] [Abstract][Full Text] [Related]
37. Crystalline silica particles induce DNA damage in respiratory epithelium by ATX secretion and Rac1 activation.
Wu R; Högberg J; Adner M; Stenius U; Zheng H
Biochem Biophys Res Commun; 2021 Apr; 548():91-97. PubMed ID: 33636640
[TBL] [Abstract][Full Text] [Related]
38. Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells.
Nikitopoulou I; Fanidis D; Ntatsoulis K; Moulos P; Mpekoulis G; Evangelidou M; Vassiliou AG; Dimakopoulou V; Jahaj E; Tsipilis S; Orfanos SE; Dimopoulou I; Angelakis E; Akinosoglou K; Vassilaki N; Tzouvelekis A; Kotanidou A; Aidinis V
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576169
[TBL] [Abstract][Full Text] [Related]
39. A 3D view of autotaxin.
Nishimasu H; Ishitani R; Aoki J; Nureki O
Trends Pharmacol Sci; 2012 Mar; 33(3):138-45. PubMed ID: 22277299
[TBL] [Abstract][Full Text] [Related]
40. The Expression Regulation and Biological Function of Autotaxin.
Zhang X; Li M; Yin N; Zhang J
Cells; 2021 Apr; 10(4):. PubMed ID: 33921676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]